Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-Label, Single-Centre Interventional Study to Evaluate the Efficacy and Safety of Dharasana Lep in Patients With Mild to Moderate Musculoskeletal Pain and Rheumatoid Arthritis.

NCT07085780 is registered in ClinicalTrials.gov with NovoBliss Research Pvt Ltd as lead sponsor.

NCT NCT07085780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07085780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-Label, Single-Centre Interventional Study to Evaluate the Efficacy and Safety of Dharasana Lep in Patients With Mild to Moderate Musculoskeletal Pain and Rheumatoid Arthritis.
Lead sponsor
NovoBliss Research Pvt Ltd
Phase
Not applicable
Overall status
Completed
Start date
July 28, 2025
Completion date
September 15, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

musculoskeletal pain, rheumatic pain